Maria Fiorella Contarino

Maria Fiorella Contarino


Assistant Professor in Neurology at the Leiden University Medical Centre (LUMC), The Netherlands, and neurologist coordinating the Deep Brain Stimulation program at the Haga Teaching Hospital in The Hague, The Netherlands.

She graduated and obtained the degree of Neurologist at the Università Cattolica del Sacro Cuore, in Rome, Italy. She received the PhD in Neuroscience at the University of Amsterdam, The Netherlands. 

She is Executive Committee member of the International Parkinson and Movement Disorders Society – European Session, Vice Chair of the Neurosurgery Study Interest Group (SIG) of the  International Parkinson and Movement Disorder Society, and mentor for the Leadership Program (LEAP) International Parkinson and Movement Disorders Society.

She is member of the European Academy of Neurology (EAN) Scientific panel for Movement Disorders

She is honorary member of the Romanian Parkinson and Movement Disorders Society since 2019.

She is Associate Editor for the journal Frontiers in Neurology – specialty session “Movement Disorders”, and is member of the review editorial board of Parkinsonism and Related Disorders, Frontiers in Psychiatry – specialty session “Neuropsychiatric Imaging and Stimulation”,  and Tremor and Other Hyperkinetic Disorders.

Research interests

Her main field of interest is the study of movement disorders, with a focus on advanced and innovative therapies and in particular neurostimulation approaches.

Furthermore, she contributed to the clinical characterization of patients with familial forms of dystonic syndromes or parkinsonism in the context of genetic studies. 

Selected recent publications (june 2020)

H-index (Web of Science) = 27

Total number of citations (Web of Science) = 3450

  1. Vendrik, K. E. W., Ooijevaar, R. E., De Jong, R. P. C., Laman, J. D., van Oosten, B. W., van Hilten, J. J., Ducarmon Q.R., Keller J.J., Kuijper E.J., Contarino , M. F. (2020). Fecal microbiota transplantation in neurological disorders. Front Cell Infect Microbiol, 2020 Mar 24;10:98. doi: 10.3389/fcimb.2020.00098. eCollection 2020.
  2. Geraedts VJ, van Hilten JJ, Contarino MF, Tannemaat MR. Unravelling the Parkinson’s disease network: Taking the connectome beyond the brain. Clin Neurophysiol. 2019 Aug 26;130(11):2017-2018. doi: 10.1016/j.clinph.2019.08.013.
  3. Geraedts VJ, van Ham RAP, Marinus J, van Hilten JJ, Mosch A, Hoffmann CFE, van der Gaag NA, Contarino MF. Intraoperative test stimulation of the subthalamic nucleus aids postoperative programming of chronic stimulation settings in Parkinson’s disease. Parkinsonism Relat Disord. 2019 Aug;65:62-66. doi: 10.1016/j.parkreldis.2019.05.017. 
  4. van Egmond ME, Contarino MF, Lugtenberg CHA, Peall KJ, Brouwer OF, Fung VSC, Roze E, Stewart RE, Willemsen MA, Wolf NI, de Koning TJ, Tijssen MA. Variable Interpretation of the Dystonia Consensus Classification Items Compromises Its Solidity. Mov Disord, 2019 Mar;34(3):317-320. doi: 10.1002/mds.27627
  5. Geraedts VJ, Boon LI, Marinus J, Gouw AA, van Hilten JJ, Stam CJ, Tannemaat MR, Contarino MF. Clinical correlates of quantitative EEG in Parkinson disease: A systematic review. Neurology. 2018 Nov 6;91(19):871-883. doi:10.1212/WNL.0000000000006473.
  6. Geraedts VJ, Marinus J, Gouw AA, Mosch A, Stam CJ, van Hilten JJ, Contarino MF, Tannemaat MR. Quantitative EEG reflects non-dopaminergic disease severity in Parkinson’s disease. Clin Neurophysiol. 2018 Aug;129(8):1748-1755.
  7. Contarino MF, Marinus J, van Hilten JJ. Does deep brain stimulation of the subthalamic nucleus prolong survival in Parkinson’s Disease? Mov Disord. 2018 Jul;33(6):947-949.
  8. Contarino MF, van Coller R, Mosch A, van der Gaag NA, Hoffmann CF. Clinical approach to delayed-onset cerebellar impairment following deep brain stimulation for tremor.  Brain 2017/05/1;140(5):e27.
  9. Contarino MF, Van Den Dool J, Balash Y, Bhatia K, Giladi N, Koelman JH, Lokkegaard A, Marti MJ, Postma M, Relja M, Skorvanek M, Speelman JD, Zoons E, Ferreira JJ, Vidailhet M, Albanese A, Tijssen MA. Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin. Front Neurol. 2017 Feb 24;8:35. doi: 10.3389/fneur.2017.00035
  10. Contarino MF, Brinke TR, Mosch A, Lelieveld W, Postma M, Odekerken VJ, Steendam-Oldekamp TE, Van Laar T, Kuijf ML, Tjepkema-Cloostermans MC, Schuurman PR. How Many Patients would Benefit from Steering Technology for Deep Brain Stimulation? Brain Stimul. 2016 Jan-Feb;9(1):144-5. doi: 10.1016/j.brs.2015.10.003. 

Complete list of peer-reviewed publications available at:

Other relevant links